on Vitruvia Medical AG (isin : CH0461931419)
Vitruvia Medical AG Reports Promising Half-Year Results for 2026
Vitruvia Medical AG has released its half-year results for 2026, aligning with expectations and confirming a positive business trajectory. The company reported a significant earnings improvement, reaching CHF 125,785.97, compared to a loss of CHF 72,889.88 in the same period the previous year. This substantial increase underscores the company's growth path.
The management has reaffirmed its optimistic outlook for the full year, relying on steady business performance and favorable trends observed in the first half of 2026. LT technologies GmbH & Co. KG, Vitruvia's wholly owned subsidiary, recorded strong performance, achieving its half-year revenue target of €1.3 million, setting the stage to meet the annual target of €2.6 million.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Vitruvia Medical AG news